{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:12:05Z","timestamp":1791803525831,"version":"4.3.4"},"reference-count":120,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.diabet.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T12:32:48Z","timestamp":1320496368000},"page":"1-13","source":"Crossref","is-referenced-by-count":114,"title":["Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies"],"prefix":"10.1016","volume":"38","author":[{"given":"V.","family":"Ph\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2011.09.003_bib0005","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Impotence. JAMA 1993;270:83\u201390.","DOI":"10.1001\/jama.270.1.83"},{"key":"10.1016\/j.diabet.2011.09.003_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/diacare.25.2.284","article-title":"Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked","volume":"25","author":"De Berardis","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.28.7.1739","article-title":"Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men","volume":"28","author":"Kalter-Leibovici","year":"2005","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabet.2011.09.003_bib0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.0742-3071.2001.00557.x","article-title":"Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients","volume":"18","author":"Siu","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0035","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.25.8.1458","article-title":"Association of type and duration of diabetes with erectile dysfunction in a large cohort of men","volume":"25","author":"Bacon","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0040","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2337\/diacare.21.11.1973","article-title":"Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici","volume":"21","author":"Fedele","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.diabres.2005.02.018","article-title":"Prevalence and risk factors for erectile dysfunction in Japanese diabetics","volume":"70","author":"Sasaki","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2011.09.003_bib0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1464-5491.2005.01789.x","article-title":"Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus","volume":"23","author":"Cho","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ijir.2010.1","article-title":"Determinants of erectile dysfunction in type 2 diabetes","volume":"22","author":"Giugliano","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.ijir.3901521","article-title":"Physical activity and erectile dysfunction: meta-analysis of population-based studies","volume":"19","author":"Cheng","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ije\/29.3.524","article-title":"Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici","volume":"29","author":"Fedele","year":"2000","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdiacomp.2003.12.005","article-title":"Ten-year incidence of self-reported erectile dysfunction in people with long-term type 1 diabetes","volume":"19","author":"Klein","year":"2005","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2011.09.003_bib0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/diacare.28.5.1201","article-title":"High proportions of erectile dysfunction in men with the metabolic syndrome","volume":"28","author":"Esposito","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0080","first-page":"355","article-title":"Relationship between metabolic syndrome and erectile dysfunction","volume":"6","author":"G\u00fcnd\u00fcz","year":"2004","journal-title":"Asian J Androl"},{"key":"10.1016\/j.diabet.2011.09.003_bib0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0090","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/oxfordjournals.aje.a117181","article-title":"Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction","volume":"140","author":"Wei","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0095","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.urology.2004.08.059","article-title":"Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both","volume":"64","author":"Giuliano","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.diabet.2011.09.003_bib0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ijir.2008.9","article-title":"Obesity and sexual dysfunction, male and female","volume":"20","author":"Esposito","year":"2008","journal-title":"Int J Impot Res"},{"issue":"Suppl 3","key":"10.1016\/j.diabet.2011.09.003_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1464-4096.2001.123.x","article-title":"Current treatments and emerging therapeutic approaches in male erectile dysfunction","volume":"88","author":"Hatzichristou","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.diabet.2011.09.003_bib0110","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes: a meta-analysis","volume":"24","author":"Anderson","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.juro.2006.08.102","article-title":"Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes","volume":"177","author":"De Berardis","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0120","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2337\/diacare.28.11.2637","article-title":"Longitudinal assessment of quality of life in patients with type 2 diabetes and self-reported erectile dysfunction","volume":"28","author":"De Berardis","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0302-2838(03)00305-1","article-title":"Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease","volume":"44","author":"Montorsi","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0130","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","article-title":"Erectile dysfunction and subsequent cardiovascular disease","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2011.09.003_bib0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4065\/84.2.108","article-title":"A population-based, longitudinal study of erectile dysfunction and future coronary artery disease","volume":"84","author":"Inman","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"1 Pt 1","key":"10.1016\/j.diabet.2011.09.003_bib0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1743-6109.2009.01576.x","article-title":"Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study","volume":"7","author":"Chew","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.ijir.3900282","article-title":"Does severity of ischemic coronary disease correlate with erectile function?","volume":"9","author":"Greenstein","year":"1997","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0150","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehl142","article-title":"Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial","volume":"27","author":"Montorsi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2011.09.003_bib0155","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2005.06.068","article-title":"Subclinical coronary artery atherosclerosis in patients with erectile dysfunction","volume":"46","author":"Chiurlia","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.ijir.3901403","article-title":"Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients","volume":"18","author":"Gazzaruso","year":"2006","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.0000133278.81226.C9","article-title":"Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients","volume":"110","author":"Gazzaruso","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2011.09.003_bib0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(02)03113-2","article-title":"Relation of erectile dysfunction to angiographic coronary artery disease","volume":"91","author":"Solomon","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0175","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.jacc.2008.02.051","article-title":"Erectile dysfunction predicts coronary heart disease in type 2 diabetes","volume":"51","author":"Ma","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0180","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2007.10.069","article-title":"Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors","volume":"51","author":"Gazzaruso","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0185","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.04.067","article-title":"Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the Advance (Action in diabetes and vascular disease: preterax and diamicron modified-release controlled evaluation) trial","volume":"56","author":"Batty","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.medcli.2008.06.009","article-title":"Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The Diva (diabetes and vascular disease) study","volume":"132","author":"Gonz\u00e1lez-Juanatey","year":"2009","journal-title":"Med Clin"},{"key":"10.1016\/j.diabet.2011.09.003_bib0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/157339911794940693","article-title":"Erectile dysfunction and coronary artery disease in patients with diabetes","volume":"7","author":"Gazzaruso","year":"2011","journal-title":"Curr Diabetes Rev"},{"issue":"12B","key":"10.1016\/j.diabet.2011.09.003_bib0200","doi-asserted-by":"crossref","first-page":"19M","DOI":"10.1016\/j.amjcard.2005.07.006","article-title":"The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease","volume":"96","author":"Montorsi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0205","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.eururo.2007.08.004","article-title":"Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links","volume":"52","author":"Vlachopoulos","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/heart.89.3.251","article-title":"Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator","volume":"89","author":"Solomon","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.diabet.2011.09.003_bib0215","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/sj.bjp.0702981","article-title":"Selective nitrergic neurodegeneration in diabetes mellitus\u00a0\u2013\u00a0a nitric oxide-dependent phenomenon","volume":"128","author":"Cellek","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CRD.0b013e3181fb7eb8","article-title":"Erectile dysfunction: a disease marker for cardiovascular disease","volume":"19","author":"Shin","year":"2011","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.diabet.2011.09.003_bib0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1463-1326.2002.00212.x","article-title":"Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes","volume":"4","author":"Wen","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2011.09.003_bib0230","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00403325","article-title":"Elevated plasma endothelin in patients with diabetes mellitus","volume":"33","author":"Takahashi","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2011.09.003_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.ijir.3900814","article-title":"Human and rabbit cavernosal smooth muscle cells express Rho-kinase","volume":"14","author":"Rees","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0240","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.urology.2011.01.009","article-title":"Erectile dysfunction is associated with severe retinopathy in diabetic men","volume":"77","author":"Henis","year":"2011","journal-title":"Urology"},{"issue":"17 Suppl 12","key":"10.1016\/j.diabet.2011.09.003_bib0245","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp070330","article-title":"Etiology and natural history of diabetic retinopathy: an overview","volume":"64","author":"Morello","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.diabet.2011.09.003_bib0250","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1536\/ihj.46.639","article-title":"Retinopathy is related to the angiographically detected severity and extent of coronary artery disease in patients with type 2 diabetes mellitus","volume":"46","author":"Norgaz","year":"2005","journal-title":"Int Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.diabet.2011.09.003_bib0255","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/j.diabres.2003.09.019","article-title":"Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes","volume":"66","author":"Yamasaki","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2011.09.003_bib0260","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1179\/016164101101198965","article-title":"Neuropathy is a major contributing factor to diabetic erectile dysfunction","volume":"23","author":"Hecht","year":"2001","journal-title":"Neurol Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0265","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1464-5491.2006.01911.x","article-title":"The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment","volume":"23","author":"Pegge","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0272.2008.00799.x","article-title":"Is erectile dysfunction a sentinel symptom for cardiovascular autonomic neuropathy in patients with type 2 diabetes?","volume":"40","author":"Debono","year":"2008","journal-title":"Andrologia"},{"key":"10.1016\/j.diabet.2011.09.003_bib0275","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic autonomic neuropathy","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.ijir.3900907","article-title":"The neuropathy of erectile dysfunction","volume":"14","author":"Bleustein","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0285","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.ijir.3901391","article-title":"Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic","volume":"18","author":"Corona","year":"2006","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2605.2007.00815.x","article-title":"Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction","volume":"31","author":"El-Sakka","year":"2008","journal-title":"Int J Androl"},{"key":"10.1016\/j.diabet.2011.09.003_bib0295","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0300","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2605.2007.00744.x","article-title":"Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes","volume":"30","author":"Kapoor","year":"2007","journal-title":"Int J Androl"},{"key":"10.1016\/j.diabet.2011.09.003_bib0305","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Br\u00fcning","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.diabet.2011.09.003_bib0310","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1464-410X.2006.06550.x","article-title":"The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus","volume":"99","author":"Al-Hunayan","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.diabet.2011.09.003_bib0315","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.diabet.2009.06.003","article-title":"Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes","volume":"35","author":"Hermans","year":"2009","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2011.09.003_bib0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.urology.2009.02.073","article-title":"Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome?","volume":"74","author":"Aslan","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.diabet.2011.09.003_bib0325","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2011.09.003_bib0330","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","article-title":"Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men","volume":"346","author":"Perry","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2011.09.003_bib0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nyg\u00e5rd","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0340","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.urology.2008.01.024","article-title":"Hyperhomocysteinemia is a risk factor for erectile dysfunction in men with adult-onset diabetes mellitus","volume":"71","author":"Al-Hunayan","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.diabet.2011.09.003_bib0345","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0350","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","article-title":"Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0355","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/157339910791658907","article-title":"Diabetes, sexual dysfunction and therapeutic exercise: a 20 year review","volume":"6","author":"Adeniyi","year":"2010","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabet.2011.09.003_bib0360","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1743-6109.2008.01209.x","article-title":"Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look Ahead trial","volume":"6","author":"Rosen","year":"2009","journal-title":"J Sex Med"},{"issue":"1 Pt 1","key":"10.1016\/j.diabet.2011.09.003_bib0365","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1743-6109.2009.01458.x","article-title":"Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial","volume":"7","author":"Wing","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0370","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.juro.2010.12.098","article-title":"Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes","volume":"185","author":"Wessells","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0375","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1743-6109.2009.01219.x","article-title":"Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes","volume":"6","author":"Lu","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0380","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14779072.4.2.173","article-title":"Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment","volume":"4","author":"Gazzaruso","year":"2006","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.diabet.2011.09.003_bib0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-6175.2002.00862.x","article-title":"Sexual dysfunction in patients with hypertension: implications for therapy","volume":"4","author":"Ferrario","year":"2002","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.diabet.2011.09.003_bib0390","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1755-5922.2009.00123.x","article-title":"Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents","volume":"28","author":"Cordero","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.diabet.2011.09.003_bib0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2605.2009.00965.x","article-title":"Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?","volume":"32","author":"Corona","year":"2009","journal-title":"Int J Androl"},{"key":"10.1016\/j.diabet.2011.09.003_bib0400","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0405","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","article-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil diabetes study group","volume":"281","author":"Rendell","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2011.09.003_bib0410","doi-asserted-by":"crossref","unstructured":"Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev 2007;CD002187.","DOI":"10.1002\/14651858.CD002187.pub3"},{"key":"10.1016\/j.diabet.2011.09.003_bib0415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.ijir.3901309","article-title":"Erectile dysfunction in patients with coronary artery disease","volume":"17","author":"Kloner","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/157339908783502389","article-title":"Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of diabetic erectile dysfunction","volume":"4","author":"Bruzziches","year":"2008","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabet.2011.09.003_bib0425","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/archinte.162.12.1349","article-title":"Sildenafil for male erectile dysfunction: a systematic review and meta-analysis","volume":"162","author":"Fink","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0430","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P","article-title":"Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men","volume":"15","author":"Price","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0435","doi-asserted-by":"crossref","unstructured":"Deyoung L, Chung E, Kovac JR, Romano W, Brock GB. Daily Use of Sildenafil Improves Endothelial Function in Type 2 Diabetic Men. J Androl. doi: 10.2164\/jandrol.111.013367.","DOI":"10.2164\/jandrol.111.013367"},{"key":"10.1016\/j.diabet.2011.09.003_bib0440","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1442-2042.2006.01480.x","article-title":"Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction","volume":"13","author":"Ishii","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0445","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1743-6109.2006.00295.x","article-title":"Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction","volume":"3","author":"Ziegler","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0450","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s00125-004-1549-6","article-title":"Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials","volume":"47","author":"Fonseca","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2011.09.003_bib0455","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1743-6109.2006.00249.x","article-title":"Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries","volume":"3","author":"Buvat","year":"2006","journal-title":"J Sex Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0460","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1520-037X.2003.01488.x","article-title":"Should the patient with coronary artery disease use sildenafil?","volume":"6","author":"Cheitlin","year":"2003","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0465","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/ENDO:23:2-3:125","article-title":"Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient","volume":"23","author":"Kloner","year":"2004","journal-title":"Endocrine"},{"key":"10.1016\/j.diabet.2011.09.003_bib0470","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00019501-200609000-00001","article-title":"Effects of tadalafil on myocardial blood flow in patients with coronary artery disease","volume":"17","author":"Weinsaft","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.diabet.2011.09.003_bib0475","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2174\/138161206778343073","article-title":"Cardiovascular effects of phosphodiesterase 5 inhibitors","volume":"12","author":"Reffelmann","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.diabet.2011.09.003_bib0480","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.ijir.3901497","article-title":"The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size","volume":"19","author":"Sesti","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0485","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2006.09.035","article-title":"Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction","volume":"196","author":"Bocchio","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabet.2011.09.003_bib0490","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0735-1097(02)02139-3","article-title":"The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia","volume":"40","author":"Halcox","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0495","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.eururo.2004.10.002","article-title":"Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk","volume":"47","author":"Rosano","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0500","doi-asserted-by":"crossref","unstructured":"Moon DG, Yang DY, Lee CH, Ahn TY, Min KS, Park K, et al. A Therapeutic confirmatory study to assess the safety and efficacy of Zydena\u00ae(Udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus. J Sex Med. doi: 10.1111\/j.1743-6109.2011.02268.x.","DOI":"10.1111\/j.1743-6109.2011.02268.x"},{"key":"10.1016\/j.diabet.2011.09.003_bib0505","doi-asserted-by":"crossref","unstructured":"Park HJ, Choi HK, Ahn TY, Park JK, Chung WS, Lee SW, et al. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial. J Sex Med. doi: 10.1111\/j.1743-6109.2010.01888.x.","DOI":"10.1111\/j.1743-6109.2010.01888.x"},{"key":"10.1016\/j.diabet.2011.09.003_bib0510","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1745-7262.2006.00223.x","article-title":"Pathophysiology and treatment of diabetic erectile dysfunction","volume":"8","author":"Moore","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1016\/j.diabet.2011.09.003_bib0515","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-5347(05)67902-5","article-title":"Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters","volume":"163","author":"Vardi","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0520","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2165\/00003495-200565120-00003","article-title":"A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?","volume":"65","author":"Hatzimouratidis","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.diabet.2011.09.003_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated urethral system for erection (Muse) study group","volume":"336","author":"Padma-Nathan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0530","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0094-0143(05)70142-7","article-title":"Vacuum constriction and external erection devices in erectile dysfunction","volume":"28","author":"Levine","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.diabet.2011.09.003_bib0535","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1464-5491.1991.tb01538.x","article-title":"The management of impotence in diabetic men by vacuum tumescence therapy","volume":"8","author":"Price","year":"1991","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2011.09.003_bib0540","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-5347(17)39679-9","article-title":"Patient acceptance of and satisfaction with an external negative pressure device for impotence","volume":"144","author":"Sidi","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0545","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0022-5347(17)41308-5","article-title":"Effect of yohimbine hydrochloride on erectile impotence: a double-blind study","volume":"141","author":"Susset","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0550","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.juro.2010.09.094","article-title":"Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of follow-up","volume":"185","author":"Carson","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0555","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.ijir.3900768","article-title":"Penile prosthesis infections","volume":"13","author":"Montague","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.diabet.2011.09.003_bib0560","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/00005392-199805000-00034","article-title":"Quantifying risk of penile prosthesis infection with elevated glycosylated haemoglobin","volume":"159","author":"Wilson","year":"1998","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.diabet.2011.09.003_bib0565","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-5347(01)67678-X","article-title":"Inflatable penile implant infection: predisposing factors and treatment suggestions","volume":"153","author":"Wilson","year":"1995","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.diabet.2011.09.003_bib0570","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0022-5347(01)65860-9","article-title":"Risk factors for penile prosthetic infection","volume":"156","author":"Jarow","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0575","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0022-5347(17)37244-0","article-title":"Use of glycosylated haemoglobin to identify diabetics at high risk for penile periprosthetic infections","volume":"147","author":"Bishop","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.diabet.2011.09.003_bib0580","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/diacare.26.2.279","article-title":"Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial","volume":"26","author":"Stuckey","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0585","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1056-8727(03)00056-4","article-title":"Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study","volume":"18","author":"Safarinejad","year":"2004","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2011.09.003_bib0590","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s001250100656","article-title":"Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus","volume":"44","author":"Boulton","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2011.09.003_bib0595","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","article-title":"Effects of tadalafil on erectile dysfunction in men with diabetes","volume":"25","author":"S\u00e1enz de Tejada","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2011.09.003_bib0600","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1464-5491.2007.02338.x","article-title":"Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction","volume":"25","author":"Hatzichristou","year":"2008","journal-title":"Diabet Med"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363611001637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363611001637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:35Z","timestamp":1560902435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363611001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1262363611001637"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2011.09.003","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}